Skip to main content
    A

    AdvanSix Inc (ASIX)

    Official site

    BASIC MATERIALS • CHEMICALS • NYSE

    $15.68
    -0.06 (-0.38%)

    Market Cap: $423.50M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    AdvanSix Inc (ASIX) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    AdvanSix (ASIX) is expected to report earnings on Feb 18, 2027. In the quarter ended Sep 30, 2026, AdvanSix reported EPS of -$0.26, below the -$0.04 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    60%(24/40)
    Avg Surprise
    -14.74%

    Upcoming Estimates

    Reports Feb 18, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.54
    Range$0.49 - $0.58
    4 analysts
    Revenue Consensus
    $404.58M
    Range$364.56M - $442.37M
    4 analysts
    Reports May 6, 2027 (est.)Period ending Mar 31, 2027
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    0 analysts

    Next Report

    ASIX has an expected report date of Feb 18, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 1700.0% above the $0.03 reported for the quarter ended Dec 31, 2025.

    ASIX Earnings Call

    The latest ASIX earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, ASIX beat 24 and missed 16. Revenue for the quarter ended Sep 30, 2026 was $430.81M, up 15.0% from $374.47M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.26-$0.04-$0.05 - -$0.04-550.00%Miss-425.0%20 up, 0 downNov 4, 2026$430.81M
    Jun 30, 2026$0.14$0.56$0.55 - $0.56-75.00%Miss-87.8%21 up, 0 downAug 7, 2026$421.28M
    Mar 31, 2026-$0.56-$0.47-$0.50 - -$0.45-19.15%Miss-160.2%20 up, 1 downMay 8, 2026$404.18M
    Dec 31, 2025$0.03-$0.06N/A+150.00%Beat-66.7%10 up, 1 downFeb 20, 2026$359.95M
    Sep 30, 2025$0.08$0.40$0.40 - $0.40-80.00%Miss-90.9%10 up, 2 downNov 7, 2025$374.47M
    Jun 30, 2025$1.15$1.11N/A+3.60%Beat-25.8%10 up, 2 downAug 1, 2025$410.02M
    Mar 31, 2025$0.93$0.83$0.81 - $0.84+12.05%BeatN/A20 up, 1 downMay 2, 2025$377.79M
    Dec 31, 2024$0.09-$0.37-$0.40 - -$0.33+124.66%BeatN/A21 up, 0 downFeb 21, 2025$329.06M
    Sep 30, 2024$0.88$0.66$0.50 - $0.81+33.33%BeatN/A20 up, 0 downNov 1, 2024$398.19M
    Jun 30, 2024$1.55$1.20$1.10 - $1.29+29.17%Beat+24.0%20 up, 0 downAug 2, 2024$453.48M
    Mar 31, 2024-$0.56-$0.54-$0.67 - -$0.47-3.70%Miss-143.1%30 up, 0 downMay 3, 2024$336.83M
    Dec 31, 2023-$0.10-$0.12N/A+16.67%Beat-107.9%20 up, 0 downFeb 16, 2024$382.21M
    Sep 30, 2023-$0.36$0.10N/A-460.00%Miss-183.7%30 up, 1 downNov 3, 2023$322.91M
    Jun 30, 2023$1.25$1.11$0.98 - $1.15+12.61%Beat-45.7%30 up, 0 downAug 4, 2023$427.94M
    Mar 31, 2023$1.30$1.02$0.77 - $1.23+27.45%Beat-42.5%30 up, 0 downMay 5, 2023$400.54M
    Dec 31, 2022$1.27$1.56$1.42 - $1.60-18.59%Miss+58.7%30 up, 0 downFeb 17, 2023$404.06M
    Sep 30, 2022$0.43$0.33N/A+30.30%Beat-71.5%30 up, 0 downNov 4, 2022$478.77M
    Jun 30, 2022$2.30$2.39$2.23 - $2.47-3.77%Miss+50.3%30 up, 0 downAug 5, 2022$583.74M
    Mar 31, 2022$2.26$1.76$1.53 - $1.90+28.41%Beat+130.6%30 up, 0 downMay 6, 2022$479.07M
    Dec 31, 2021$0.80$0.81$0.64 - $0.91-1.23%Miss-14.9%30 up, 0 downFeb 18, 2022$424.06M
    Sep 30, 2021$1.51$1.27$1.25 - $1.30+18.90%BeatN/A2N/AOct 29, 2021$446.50M
    Jun 30, 2021$1.53$1.08$0.85 - $1.31+41.67%Beat+273.2%2N/AJul 30, 2021$437.68M
    Mar 31, 2021$0.98$0.72$0.66 - $0.77+36.11%Beat+216.1%2N/AApr 30, 2021$376.38M
    Dec 31, 2020$0.94$0.49$0.41 - $0.56+91.84%BeatN/A3N/AFeb 19, 2021$340.27M
    Sep 30, 2020-$0.02$0.04-$0.10 - $0.04-150.00%Miss-107.1%3N/AOct 30, 2020$281.91M
    Jun 30, 2020$0.41$0.37$0.25 - $0.39+10.81%Beat-51.8%3N/AJul 31, 2020$233.02M
    Mar 31, 2020$0.31$0.16$0.15 - $0.18+93.75%Beat-54.4%3N/AMay 1, 2020$302.71M
    Dec 31, 2019-$0.11-$0.08-$0.20 - $0.00-37.50%Miss-116.2%3N/AFeb 21, 2020$326.65M
    Sep 30, 2019$0.28$0.45$0.34 - $0.56-37.78%Miss+55.6%4N/ANov 1, 2019$310.63M
    Jun 30, 2019$0.85$0.39$0.24 - $0.54+117.95%Beat-6.6%3N/AAug 1, 2019$345.21M
    Mar 31, 2019$0.68$0.39$0.37 - $0.40+74.36%Beat+83.8%2N/AMay 3, 2019$314.89M
    Dec 31, 2018$0.68$0.75$0.68 - $0.86-9.33%Miss+13.3%3N/AFeb 22, 2019$386.63M
    Sep 30, 2018$0.18$0.27$0.27 - $0.33-33.33%Miss-73.5%2N/ANov 2, 2018$368.65M
    Jun 30, 2018$0.91$0.90$0.84 - $0.90+1.11%Beat+9.6%2N/AAug 3, 2018$400.46M
    Mar 31, 2018$0.37$0.22$0.22 - $0.30+68.18%Beat-58.0%2N/AMay 4, 2018$359.24M
    Dec 31, 2017$0.60$0.44$0.38 - $0.50+36.36%BeatN/A2N/AFeb 23, 2018$370.19M
    Sep 30, 2017$0.68$0.77$0.55 - $0.77-11.69%Miss+25.9%2N/ANov 7, 2017$366.66M
    Jun 30, 2017$0.83$0.66$0.54 - $0.66+25.76%BeatN/A2N/AAug 10, 2017$361.44M
    Mar 31, 2017$0.88$0.43N/A+104.65%BeatN/AN/AN/AMay 11, 2017$376.70M
    Dec 31, 2016-$0.81$0.43N/A-288.37%MissN/AN/AN/AMar 3, 2017$259.80M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $2.19, up 11.7% from the year before. It was -$0.27 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$2.19+11.7%
    Dec 31, 2024$1.96-6.2%
    Dec 31, 2023$2.09-66.6%
    Dec 31, 2022$6.26+29.9%
    Dec 31, 2021$4.82+193.9%
    Dec 31, 2020$1.64-3.5%
    Dec 31, 2019$1.70-20.6%
    Dec 31, 2018$2.14-28.4%
    Dec 31, 2017$2.99N/A
    Dec 31, 2016-$0.27N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,000 words across 6 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,0176
    2026Q2Jun 30, 20264,4626
    2026Q1Mar 31, 20263,7586
    2025Q4Dec 31, 20255,6656
    2025Q3Sep 30, 20254,2145
    2025Q2Jun 30, 20253,5645
    2025Q1Mar 31, 20255,2946
    2024Q4Dec 31, 20245,5466

    2026Q3 Earnings Call

    Opening remarks

    Adam Kressel Vice President, Investor Relations and Treasurer Thank you, Danielle. Good morning, and welcome to AdvanSix's third quarter 2026 earnings conference call. With me here today are President and CEO, Erin Kane, and Senior Vice President and CFO, Patrick Day. This call and webcast, including any non-GAAP reconciliations, are available on our website at investors.advansix.com. Note that elements of this presentation contain forward-looking statements that are based on our best view of the world and of our business as we see it today. Those elements can change, and the actual results could differ materially from those projected, and we ask that you consider them in that light. We refer you to the forward-looking statements included in our press release and earnings presentation. In addition, we identify the principal risks and uncertainties that affect our performance in our SEC filings, including our annual report on Form 10-K, as further updated in subsequent filings with the SEC. This morning, we will review our financial results for the third quarter of 2026 and share our outlook for our key product lines and end markets. Finally, we will leave time for your questions at the end. With that, I will turn the call over to AdvanSix's President and CEO, Erin Kane.

    Erin Kane President and CEO Thanks, Adam, and good morning, everyone. We appreciate you joining us here today for our quarterly call. As you saw in our press release, we generated 15% sales growth year-over-year as our teams continued to leverage both formula- and market-based pricing mechanisms to offset inflationary raw material costs. We also generated improved cash flow, benefiting from disciplined working capital performance and continued risk-based prioritization of base capital spending. While our core caprolactam operating rate continues to exceed global industry averages by nearly 10%, reduced production output at our Hopewell and backward-integrated Frankford manufacturing sites drove unfavorable fixed cost absorption. Patrick will dive into the financials in a moment, but I would like to start the discussion once again by framing our key strategic priorities. Our focus remains centered on the controllable levers that support through-cycle value creation: commercial execution, operational excellence, and disciplined capital deployment. Once again, our pricing actions in aggregate nearly offset the substantial year-over-year increase in raw materials. We are maintaining margin expansion across Nylon Solutions and Chemical Intermediates. In Plant Nutrients, while we continue to navigate elevated sulfur costs, we do expect strong domestic granular ammonium sulfate volume performance for the full 2026–2027 fertilizer year. Turning to operational excellence, we are focused on supporting safe, stable, and sustainable operations while improving earnings and cash conversion through the cycle. Our approach includes risk-based capital prioritization, disciplined turnaround scoping, and the use of continuous improvement as a productivity engine across the enterprise.

    Frequently Asked Questions About ASIX

    When is AdvanSix's next earnings date?

    AdvanSix's next earnings report is expected for Feb 18, 2027.

    Did ASIX beat earnings estimates last quarter?

    No. AdvanSix reported EPS of -$0.26 for the quarter ended Sep 30, 2026, below the -$0.04 estimate by 550.00%.

    What EPS do analysts expect from ASIX next quarter?

    The consensus EPS estimate for AdvanSix for the quarter ending Dec 31, 2026 is $0.54 from 4 analysts, with estimates from $0.49 to $0.58.

    How often does ASIX beat earnings estimates?

    AdvanSix beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -54.23%.